Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig06101 |
---NA--- |
343 |
0 |
|
|
0 |
|
|
|
contig06102 |
---NA--- |
307 |
0 |
|
|
0 |
|
|
|
contig06103 |
basic leucine zipper and w2 domains 1 |
363 |
20 |
4.04E-48 |
95.25% |
4 |
P:regulation of translational initiation; P:transcription antitermination; F:translation initiation factor activity; P:regulation of transcription, DNA-dependent |
|
|
contig06104 |
ae binding protein 2 |
543 |
20 |
2.75E-87 |
88.60% |
5 |
F:DNA binding; F:transcription corepressor activity; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-dependent |
|
|
contig06105 |
expressed sequence aw549877 |
518 |
19 |
1.52E-86 |
71.89% |
0 |
|
|
|
contig06106 |
tetraodon protein product cag00085 |
273 |
2 |
8.53E-22 |
66.50% |
0 |
|
|
|
contig06107 |
---NA--- |
420 |
0 |
|
|
0 |
|
|
|
contig06108 |
nuclear rna export factor 1 |
250 |
20 |
8.47E-14 |
84.05% |
7 |
C:nuclear pore; C:nuclear inclusion body; F:mRNA binding; F:nucleocytoplasmic transporter activity; F:protein binding; P:poly(A)+ mRNA export from nucleus; F:nucleotide binding |
|
|
contig06109 |
mon1 homolog b |
399 |
20 |
6.12E-60 |
87.95% |
0 |
|
|
|
contig06110 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
contig06111 |
---NA--- |
293 |
0 |
|
|
0 |
|
|
|
contig06112 |
adaptor-related protein complex mu 1 subunit |
278 |
20 |
5.47E-45 |
99.80% |
8 |
P:protein complex assembly; C:Golgi apparatus; C:lysosome; F:protein binding; P:protein targeting to lysosome; F:protein transporter activity; P:vesicle-mediated transport; C:clathrin adaptor complex |
|
|
contig06113 |
non-smc condensin i subunit h |
269 |
20 |
6.16E-20 |
66.40% |
2 |
P:mitosis; C:nucleus |
|
|
contig06114 |
subfamily member 6 |
247 |
20 |
4.35E-18 |
98.80% |
6 |
C:cytoplasm; P:negative regulation of transcription, DNA-dependent; F:DNA binding; F:heat shock protein binding; C:nucleus; F:transcription repressor activity |
|
|
contig06115 |
---NA--- |
242 |
0 |
|
|
0 |
|
|
|
contig06116 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig06117 |
---NA--- |
611 |
0 |
|
|
0 |
|
|
|
contig06118 |
cellular apoptosis susceptibility protein |
264 |
20 |
1.13E-05 |
99.75% |
12 |
C:nuclear pore; P:protein transport; F:protein transporter activity; C:nucleus; P:transport; P:apoptosis; P:protein import into nucleus, docking; C:cytoplasm; P:intracellular protein transport; F:importin-alpha export receptor activity; F:binding; P:cell proliferation |
|
|
contig06119 |
---NA--- |
211 |
0 |
|
|
0 |
|
|
|
contig06120 |
#NAME? |
495 |
20 |
8.49E-25 |
85.10% |
4 |
P:metabolic process; F:2,4-dienoyl-CoA reductase (NADPH) activity; C:mitochondrion; F:binding |
EC:1.3.1.34 |
|
contig06121 |
rna terminal phosphate cyclase domain 1 |
327 |
20 |
8.90E-11 |
80.15% |
6 |
F:RNA-3'-phosphate cyclase activity; F:ligase activity, forming phosphoric ester bonds; F:ligase activity; F:catalytic activity; P:RNA processing; C:nucleus |
|
|
contig06122 |
---NA--- |
193 |
0 |
|
|
0 |
|
|
|
contig06123 |
---NA--- |
257 |
0 |
|
|
0 |
|
|
|
contig06124 |
voltage-dependent anion channel 3 |
262 |
20 |
4.76E-12 |
89.55% |
4 |
P:anion transport; F:voltage-gated anion channel activity; C:membrane attack complex; C:mitochondrial outer membrane |
|
|
contig06125 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig06126 |
hyaluronan mediated motility receptor |
547 |
19 |
4.41E-16 |
78.21% |
3 |
F:hyaluronic acid binding; P:cytoskeleton organization; P:cell-cell signaling |
|
|
contig06127 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig06128 |
---NA--- |
362 |
0 |
|
|
0 |
|
|
|
contig06129 |
amine oxidase (flavin containing) domain 2 |
999 |
20 |
2.17E-147 |
96.35% |
11 |
P:chromatin modification; P:pituitary gland development; P:positive regulation of hormone biosynthetic process; P:positive regulation of transcription from RNA polymerase II promoter; C:transcription factor complex; P:negative regulation of transcription from RNA polymerase II promoter; F:oxidoreductase activity; F:transcription factor activity; F:transcription factor binding; P:cell proliferation; P:in utero embryonic development |
|
|
contig06130 |
mgc108224 protein |
366 |
20 |
8.42E-30 |
65.45% |
1 |
F:transferase activity |
|
|
contig06131 |
unnamed protein product [Tetraodon nigroviridis] |
300 |
1 |
5.56E-13 |
60.00% |
0 |
|
|
|
contig06132 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig06133 |
---NA--- |
249 |
0 |
|
|
0 |
|
|
|
contig06134 |
---NA--- |
549 |
0 |
|
|
0 |
|
|
|
contig06135 |
x-ray repair complementing defective repair in chinese hamster cells 1 |
326 |
20 |
4.88E-25 |
95.35% |
5 |
P:single strand break repair; P:base-excision repair; C:nucleus; F:damaged DNA binding; F:protein binding |
|
|
contig06136 |
chromosome 14 open reading frame 169 |
483 |
20 |
1.48E-29 |
70.75% |
5 |
P:ribosome biogenesis; F:RNA binding; P:transcription; P:chromatin remodeling; C:nucleolar preribosome |
|
|
contig06137 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig06138 |
ctage member 5 |
244 |
20 |
1.09E-21 |
82.00% |
2 |
F:protein binding; F:enzyme activator activity |
|
|
contig06139 |
poly binding nuclear 1 |
344 |
20 |
1.39E-27 |
72.40% |
7 |
C:cytoplasm; P:mRNA polyadenylation; P:muscle contraction; F:protein binding; F:poly(A) RNA binding; C:nucleus; F:nucleotide binding |
|
|
contig06140 |
k0841 protein |
209 |
2 |
5.19E-11 |
71.00% |
2 |
F:F; C:C |
|
|
contig06141 |
e3 ubiquitin-protein ligase march3 |
391 |
1 |
1.19E-07 |
57.00% |
0 |
|
|
|
contig06142 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig06143 |
---NA--- |
249 |
0 |
|
|
0 |
|
|
|
contig06144 |
---NA--- |
108 |
0 |
|
|
0 |
|
|
|
contig06145 |
endonuclease g |
260 |
20 |
1.09E-32 |
89.00% |
6 |
C:extracellular space; F:endonuclease activity; F:manganese ion binding; F:nucleic acid binding; F:magnesium ion binding; C:mitochondrion |
|
|
contig06146 |
---NA--- |
240 |
0 |
|
|
0 |
|
|
|
contig06147 |
---NA--- |
265 |
0 |
|
|
0 |
|
|
|
contig06148 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig06149 |
unnamed protein product [Tetraodon nigroviridis] |
279 |
1 |
1.31E-22 |
71.00% |
0 |
|
|
|
contig06150 |
apolipoprotein o |
540 |
20 |
8.83E-22 |
76.95% |
1 |
C:membrane |
|
|
contig06151 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
contig06152 |
novel protein |
331 |
20 |
4.37E-34 |
67.65% |
0 |
|
|
|
contig06153 |
---NA--- |
204 |
0 |
|
|
0 |
|
|
|
contig06154 |
---NA--- |
311 |
0 |
|
|
0 |
|
|
|
contig06155 |
ubiquinol-cytochrome c reductase core protein ii |
258 |
2 |
9.65E-05 |
79.00% |
4 |
F:metal ion binding; F:catalytic activity; F:metalloendopeptidase activity; F:zinc ion binding |
|
|
contig06156 |
---NA--- |
329 |
0 |
|
|
0 |
|
|
|
contig06157 |
---NA--- |
311 |
0 |
|
|
0 |
|
|
|
contig06158 |
interleukin enhancer binding factor 2 |
266 |
20 |
2.11E-44 |
98.10% |
10 |
C:nucleolus; P:immune response; F:DNA binding; F:double-stranded RNA binding; F:ATP binding; F:transferase activity; F:protein binding; P:transcription antitermination; P:positive regulation of transcription, DNA-dependent; F:RNA polymerase II transcription factor activity |
|
|
contig06159 |
---NA--- |
212 |
0 |
|
|
0 |
|
|
|
contig06160 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
contig06161 |
sorting nexin 14 |
256 |
20 |
1.75E-30 |
84.75% |
7 |
F:phosphoinositide binding; F:signal transducer activity; ; F:protein binding; F:protein transporter activity; P:intracellular protein transport; C:integral to membrane |
|
|
contig06162 |
---NA--- |
414 |
0 |
|
|
0 |
|
|
|
contig06163 |
pyruvate dehydrogenase phosphatase isoenzyme 2 |
666 |
20 |
1.69E-49 |
77.55% |
9 |
C:protein serine/threonine phosphatase complex; F:[pyruvate dehydrogenase (lipoamide)] phosphatase activity; F:protein complex binding; C:mitochondrial matrix; P:protein amino acid dephosphorylation; F:calcium ion binding; F:magnesium-dependent protein serine/threonine phosphatase activity; F:magnesium ion binding; P:positive regulation of catalytic activity |
EC:3.1.3.43 |
|
contig06164 |
cxxc finger 1 (phd domain) |
506 |
20 |
3.69E-63 |
76.85% |
10 |
C:nuclear matrix; F:zinc ion binding; P:zinc ion transport; P:hemopoiesis; P:regulation of transcription, DNA-dependent; F:unmethylated CpG binding; F:transcription activator activity; F:protein binding; P:DNA methylation on cytosine; P:blood vessel development |
|
|
contig06165 |
hcls1 associated x-1 |
240 |
20 |
2.66E-23 |
73.05% |
5 |
C:microsome; F:protein binding; C:clathrin-coated vesicle; P:cell surface receptor linked signaling pathway; C:mitochondrion |
|
|
contig06166 |
---NA--- |
301 |
0 |
|
|
0 |
|
|
|
contig06167 |
occludin a |
254 |
4 |
7.44E-05 |
86.00% |
0 |
|
|
|
contig06168 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig06169 |
zinc finger (ccch type) rna binding motif and serine arginine rich 2 |
243 |
20 |
2.23E-38 |
85.10% |
5 |
C:nucleolus; F:RNA binding; C:ribonucleoprotein complex; F:nucleotide binding; F:zinc ion binding |
|
|
contig06170 |
---NA--- |
281 |
0 |
|
|
0 |
|
|
|
contig06171 |
musashi homolog 2 |
368 |
20 |
5.83E-39 |
83.80% |
4 |
C:cytoplasm; F:poly(U) RNA binding; C:polysome; F:nucleotide binding |
|
|
contig06172 |
---NA--- |
355 |
0 |
|
|
0 |
|
|
|
contig06173 |
---NA--- |
169 |
0 |
|
|
0 |
|
|
|
contig06174 |
---NA--- |
291 |
0 |
|
|
0 |
|
|
|
contig06175 |
---NA--- |
385 |
0 |
|
|
0 |
|
|
|
contig06176 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig06177 |
---NA--- |
327 |
0 |
|
|
0 |
|
|
|
contig06178 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig06179 |
sumo-conjugating enzyme ubc9 |
496 |
20 |
1.19E-26 |
98.20% |
0 |
|
|
|
contig06180 |
---NA--- |
426 |
0 |
|
|
0 |
|
|
|
contig06181 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig06182 |
anaphase promoting complex subunit 2 |
493 |
20 |
3.00E-75 |
74.60% |
6 |
P:mitotic cell cycle; P:cyclin catabolic process; C:extracellular space; F:ubiquitin-protein ligase activity; P:cell cycle phase; P:regulation of cyclin-dependent protein kinase activity |
EC:6.3.2.19 |
|
contig06183 |
cytochrome c oxidase subunit i |
341 |
20 |
3.78E-38 |
93.55% |
9 |
P:aerobic respiration; F:copper ion binding; F:iron ion binding; F:heme binding; P:electron transport; P:transport; C:integral to membrane; F:cytochrome-c oxidase activity; C:mitochondrial respiratory chain |
EC:1.9.3.1 |
|
contig06184 |
ccr4-not transcription subunit 10 |
315 |
20 |
1.86E-48 |
93.25% |
1 |
F:binding |
|
|
contig06185 |
novel protein (zgc:63624) |
244 |
2 |
1.97E-10 |
76.00% |
0 |
|
|
|
contig06186 |
---NA--- |
172 |
0 |
|
|
0 |
|
|
|
contig06187 |
---NA--- |
151 |
0 |
|
|
0 |
|
|
|
contig06188 |
pq loop repeat containing 2 |
240 |
20 |
1.67E-17 |
76.95% |
1 |
C:membrane |
|
|
contig06189 |
---NA--- |
426 |
0 |
|
|
0 |
|
|
|
contig06190 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig06191 |
gemin 4 |
415 |
20 |
7.62E-39 |
53.15% |
11 |
P:mRNA processing; C:small nuclear ribonucleoprotein complex; C:nucleus; P:RNA splicing; P:rRNA processing; C:cytoplasm; F:F; C:spliceosomal complex; C:nucleolus; F:protein binding; P:P |
|
|
contig06192 |
ubiquinol-cytochrome c reductase core protein ii |
246 |
20 |
1.40E-32 |
83.85% |
3 |
F:metalloendopeptidase activity; P:proteolysis; F:zinc ion binding |
EC:3.4.24.0 |
|
contig06193 |
---NA--- |
241 |
0 |
|
|
0 |
|
|
|
contig06194 |
---NA--- |
391 |
0 |
|
|
0 |
|
|
|
contig06195 |
riken cdna 2310011j03 |
698 |
18 |
4.01E-20 |
69.72% |
1 |
F:protein binding |
|
|
contig06196 |
mothers against decapentaplegic homolog 7 |
282 |
20 |
5.66E-18 |
94.25% |
10 |
P:regulation of transcription, DNA-dependent; C:transcription factor complex; P:regulation of transforming growth factor beta receptor signaling pathway; F:protein binding; F:transcription factor activity; P:common-partner SMAD protein phosphorylation; P:transcription antitermination; P:negative regulation of transcription; ; C:cytoplasm |
|
|
contig06197 |
---NA--- |
317 |
0 |
|
|
0 |
|
|
|
contig06198 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
contig06199 |
member of ras oncogene family-like 4 |
504 |
20 |
8.01E-34 |
71.05% |
1 |
F:nucleotide binding |
|
|
contig06200 |
ectonucleoside triphosphate diphosphohydrolase 4 |
506 |
20 |
6.16E-18 |
67.35% |
3 |
F:uridine-diphosphatase activity; C:integral to Golgi membrane; P:UDP catabolic process |
|
|
100 Rows returned.